Keene & Associates’s Procter & Gamble PG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,361
Closed -$383K 80
2024
Q1
$383K Buy
2,361
+14
+0.6% +$2.2K 0.29% 64
2023
Q4
$344K Buy
2,347
+13
+0.6% +$1.93K 0.29% 61
2023
Q3
$340K Buy
2,334
+13
+0.6% +$1.99K 0.27% 58
2023
Q2
$352K Buy
2,321
+13
+0.6% +$1.96K 0.27% 56
2023
Q1
$343K Buy
2,308
+14
+0.6% +$2K 0.27% 59
2022
Q4
$348K Buy
2,294
+14
+0.6% +$1.96K 0.31% 53
2022
Q3
$288K Buy
2,280
+1,041
+84% +$148K 0.26% 58
2022
Q2
$404K Hold
1,239
0.38% 43
2022
Q1
$379K Sell
1,239
-1,004
-45% -$157K 0.31% 53
2021
Q4
$367K Buy
+2,243
New +$333K 0.32% 55

Other funds holding PG

Keene & Associates's PG Position: Q2 2024 in Review

Keene & Associates sold out of Procter & Gamble (PG) in Q2 2024, closing a stake of 2,361 shares — an estimated $383K sold.

Keene & Associates first reported a position in PG in Q4 2021 and held it in 10 quarters. The position peaked at $404K in Q2 2022. 3,653 funds tracked by Wall St. Rank hold PG as of Q2 2024.

  • Keene & Associates reported no remaining Procter & Gamble position as of Q2 2024 after selling out during the quarter.
  • Keene & Associates sold 2,361 Procter & Gamble shares in Q2 2024, an estimated $383K.
  • Keene & Associates first reported a position in Procter & Gamble in Q4 2021 and held it in 10 quarters.
  • Keene & Associates's Procter & Gamble position peaked at $404K in Q2 2022.
  • 3,653 funds tracked by Wall St. Rank held Procter & Gamble as of Q2 2024.

Based on Keene & Associates's 13F filing for Q2 2024, filed 9 Aug 2024.